Barclays’s ChemoCentryx, Inc. CCXI Stock Holding History

Barclays’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-231,500	Closed	-$3.96M	–	4908
2021 Q3	$3.96M	Sell	231,500 -72,100	-24%	-$1.12M	﹤0.01%	1784
2021 Q2	$4.07M	Buy	+303,600	New	+$7.48M	﹤0.01%	1721
2020 Q3	–	Sell	-100,000	Closed	-$5.75M	–	5735
2020 Q2	$5.75M	Hold	100,000	–	–	﹤0.01%	1278
2020 Q1	$4.02M	Buy	+100,000	New	+$4.25M	﹤0.01%	1658

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Barclays's CCXI Position: Q4 2022 in Review

Barclays sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 116,113 shares — an estimated $6M sold.

Barclays first reported a position in CCXI in Q2 2013 and held it in 38 quarters. The position peaked at $13.6M in Q2 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Barclays reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Barclays sold 116,113 ChemoCentryx, Inc. shares in Q4 2022, an estimated $6M.
Barclays first reported a position in ChemoCentryx, Inc. in Q2 2013 and held it in 38 quarters.
Barclays's ChemoCentryx, Inc. position peaked at $13.6M in Q2 2022.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.